The world's biggest maker of health care products is on the mend, with a slight increase in sales and profit after the recession dragged results down last year.
Johnson & Johnson says its first-quarter profit is up 29%, to $4.53 billion, but that's mainly due to a one-time gain from litigation. That profit represents earnings of $1.62 per share, or $1.29 excluding the gain.
The New Brunswick, N.J.-based maker of biologic drugs, Band-Aids and baby shampoo says sales were up 4%, to $15.63 billion.
The results are slightly better than experts' forecasts. Analysts polled by Thomson Reuters expected J&J to earn $1.27 per share on sales of $15.6 billion.
